Wells Fargo’s Integra LifeSciences IART Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.14M | Buy |
63,358
+30,998
| +96% | +$434K | ﹤0.01% | 4010 |
|
|
2026
Q1 | $305K | Sell |
32,360
-46,174
| -59% | -$507K | ﹤0.01% | 4440 |
|
|
2025
Q4 | $975K | Buy |
78,534
+23,492
| +43% | +$312K | ﹤0.01% | 3990 |
|
|
2025
Q3 | $789K | Buy |
55,042
+8,434
| +18% | +$116K | ﹤0.01% | 3974 |
|
|
2025
Q2 | $572K | Sell |
46,608
-161
| -0.3% | -$2.34K | ﹤0.01% | 4040 |
|
|
2025
Q1 | $1.03M | Sell |
46,769
-8,083
| -15% | -$190K | ﹤0.01% | 3637 |
|
|
2024
Q4 | $1.24M | Sell |
54,852
-85,466
| -61% | -$1.87M | ﹤0.01% | 3546 |
|
|
2024
Q3 | $2.55M | Sell |
140,318
-40,732
| -22% | -$944K | ﹤0.01% | 2865 |
|
|
2024
Q2 | $5.28M | Sell |
181,050
-252,677
| -58% | -$7.49M | ﹤0.01% | 2203 |
|
|
2024
Q1 | $15.4M | Sell |
433,727
-117,153
| -21% | -$4.69M | ﹤0.01% | 1401 |
|
|
2023
Q4 | $24M | Buy |
550,880
+264,128
| +92% | +$10.4M | 0.01% | 1069 |
|
|
2023
Q3 | $11M | Sell |
286,752
-462,499
| -62% | -$19.5M | ﹤0.01% | 1495 |
|
|
2023
Q2 | $30.8M | Sell |
749,251
-331,208
| -31% | -$15.9M | 0.01% | 902 |
|
|
2023
Q1 | $62M | Buy |
1,080,459
+108,583
| +11% | +$6.12M | 0.02% | 615 |
|
|
2022
Q4 | $54.5M | Buy |
971,876
+239,745
| +33% | +$12.2M | 0.02% | 639 |
|
|
2022
Q3 | $31M | Sell |
732,131
-211,326
| -22% | -$10.8M | 0.01% | 850 |
|
|
2022
Q2 | $51M | Sell |
943,457
-168,626
| -15% | -$10.1M | 0.02% | 662 |
|
|
2022
Q1 | $71.5M | Buy |
1,112,083
+25,301
| +2% | +$1.67M | 0.02% | 618 |
|
|
2021
Q4 | $72.8M | Sell |
1,086,782
-52,406
| -5% | -$3.55M | 0.02% | 619 |
|
|
2021
Q3 | $78M | Buy |
1,139,188
+124,291
| +12% | +$8.78M | 0.02% | 792 |
|
|
2021
Q2 | $69.3M | Buy |
1,014,897
+100,882
| +11% | +$7.13M | 0.02% | 868 |
|
|
2021
Q1 | $63.1M | Buy |
914,015
+63,782
| +8% | +$4.32M | 0.01% | 930 |
|
|
2020
Q4 | $55.2M | Buy |
850,233
+87,492
| +11% | +$4.71M | 0.01% | 925 |
|
|
2020
Q3 | $36M | Sell |
762,741
-49,107
| -6% | -$2.34M | 0.01% | 1038 |
|
|
2020
Q2 | $38.1M | Sell |
811,848
-50,783
| -6% | -$2.5M | 0.01% | 1002 |
|
|
2020
Q1 | $38.5M | Buy |
862,631
+645,157
| +297% | +$33.9M | 0.01% | 898 |
|
|
2019
Q4 | $12.7M | Buy |
217,474
+3,573
| +2% | +$213K | ﹤0.01% | 1790 |
|
|
2019
Q3 | $12.8M | Sell |
213,901
-780
| -0.4% | -$46.5K | ﹤0.01% | 1759 |
|
|
2019
Q2 | $12M | Sell |
214,681
-9,152
| -4% | -$471K | ﹤0.01% | 1827 |
|
|
2019
Q1 | $12.5M | Buy |
223,833
+17,457
| +8% | +$889K | ﹤0.01% | 1770 |
|
|
2018
Q4 | $9.31M | Sell |
206,376
-4,950
| -2% | -$272K | ﹤0.01% | 1909 |
|
|
2018
Q3 | $13.9M | Sell |
211,326
-538,906
| -72% | -$33.5M | ﹤0.01% | 1805 |
|
|
2018
Q2 | $48.3M | Sell |
750,232
-91,028
| -11% | -$5.64M | 0.01% | 925 |
|
|
2018
Q1 | $46.6M | Sell |
841,260
-28,277
| -3% | -$1.48M | 0.01% | 943 |
|
|
2017
Q4 | $41.6M | Buy |
869,537
+63,204
| +8% | +$3.09M | 0.01% | 996 |
|
|
2017
Q3 | $40.7M | Sell |
806,333
-537,126
| -40% | -$27.6M | 0.01% | 984 |
|
|
2017
Q2 | $73.2M | Sell |
1,343,459
-1,124,433
| -46% | -$53.7M | 0.02% | 679 |
|
|
2017
Q1 | $104M | Sell |
2,467,892
-1,716,178
| -41% | -$73.3M | 0.03% | 516 |
|
|
2016
Q4 | $179M | Buy |
4,184,070
+524,634
| +14% | +$21.3M | 0.06% | 316 |
|
|
2016
Q3 | $151M | Buy |
3,659,436
+354,986
| +11% | +$14.9M | 0.06% | 369 |
|
|
2016
Q2 | $132M | Buy |
3,304,450
+93,020
| +3% | +$3.35M | 0.05% | 395 |
|
|
2016
Q1 | $108M | Buy |
3,211,430
+299,572
| +10% | +$9.33M | 0.04% | 444 |
|
|
2015
Q4 | $98.7M | Buy |
2,911,858
+1,307,166
| +81% | +$40.9M | 0.04% | 473 |
|
|
2015
Q3 | $47.8M | Sell |
1,604,692
-323,182
| -17% | -$10.1M | 0.02% | 766 |
|
|
2015
Q2 | $53.1M | Sell |
1,927,874
-486,517
| -20% | -$13M | 0.02% | 777 |
|
|
2015
Q1 | $60.8M | Sell |
2,414,391
-130,686
| -5% | -$3.09M | 0.02% | 695 |
|
|
2014
Q4 | $56.4M | Sell |
2,545,077
-17,111
| -0.7% | -$347K | 0.02% | 702 |
|
|
2014
Q3 | $52M | Sell |
2,562,188
-552,046
| -18% | -$11M | 0.02% | 726 |
|
|
2014
Q2 | $59.9M | Buy |
3,114,234
+107,058
| +4% | +$1.99M | 0.02% | 690 |
|
|
2014
Q1 | $56.5M | Buy |
3,007,176
+157,577
| +6% | +$3.04M | 0.02% | 706 |
|
|
2013
Q4 | $55.6M | Buy |
2,849,599
+2,191,730
| +333% | +$40.2M | 0.02% | 704 |
|
|
2013
Q3 | $10.8M | Buy |
657,869
+182,096
| +38% | +$2.92M | 0.01% | 1593 |
|
|
2013
Q2 | $7.12M | Buy |
+475,773
| New | +$6.97M | ﹤0.01% | 1833 |
|
Other funds holding IART
RCMNY
PCMI
Wells Fargo's IART Position: Q2 2026 in Review
Wells Fargo increased its Integra LifeSciences (IART) stake by 96% in Q2 2026, buying an estimated $434K and bringing the position to 63,358 shares worth $1.14M. The position accounts for ﹤0.01% of the portfolio, ranked #4010.
Wells Fargo first reported a position in IART in Q2 2013 and has held it in 53 quarters since. The position peaked at $179M in Q4 2016. 212 funds tracked by Wall St. Rank hold IART as of Q2 2026.
- Wells Fargo held 63,358 shares of Integra LifeSciences worth $1.14M as of Q2 2026.
- Wells Fargo bought 30,998 Integra LifeSciences shares in Q2 2026, an estimated $434K.
- Integra LifeSciences made up ﹤0.01% of Wells Fargo's portfolio in Q2 2026, its #4010 holding.
- Wells Fargo first reported a position in Integra LifeSciences in Q2 2013 and has held it in 53 quarters since.
- Wells Fargo's Integra LifeSciences position peaked at $179M in Q4 2016.
- 212 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2026.
Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.